PT96229A - Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico - Google Patents

Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico

Info

Publication number
PT96229A
PT96229A PT96229A PT9622990A PT96229A PT 96229 A PT96229 A PT 96229A PT 96229 A PT96229 A PT 96229A PT 9622990 A PT9622990 A PT 9622990A PT 96229 A PT96229 A PT 96229A
Authority
PT
Portugal
Prior art keywords
dry
tablets
drug
powder compositions
naproxen
Prior art date
Application number
PT96229A
Other languages
English (en)
Other versions
PT96229B (pt
Inventor
Roy Kuramoto
Zakauddin Tanwir Chowhan
Randal Owen Pendleton
Hafez Hafezzadeh
Original Assignee
Syntex Pharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Pharma Int filed Critical Syntex Pharma Int
Publication of PT96229A publication Critical patent/PT96229A/pt
Publication of PT96229B publication Critical patent/PT96229B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT96229A 1989-12-22 1990-12-18 Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico PT96229B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45510989A 1989-12-22 1989-12-22

Publications (2)

Publication Number Publication Date
PT96229A true PT96229A (pt) 1991-09-30
PT96229B PT96229B (pt) 1998-06-30

Family

ID=23807439

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96229A PT96229B (pt) 1989-12-22 1990-12-18 Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico

Country Status (16)

Country Link
EP (1) EP0436373B1 (pt)
JP (1) JPH05320045A (pt)
KR (1) KR910011241A (pt)
AT (1) ATE110267T1 (pt)
AU (1) AU640725B2 (pt)
CA (1) CA2032956A1 (pt)
DE (1) DE69011836T2 (pt)
ES (1) ES2063296T3 (pt)
FI (1) FI906372A (pt)
HU (1) HUT59594A (pt)
IE (1) IE904666A1 (pt)
IL (1) IL96749A0 (pt)
NO (1) NO905557L (pt)
NZ (1) NZ236631A (pt)
PT (1) PT96229B (pt)
ZA (1) ZA9010353B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993020808A1 (en) * 1992-04-15 1993-10-28 Marion Merrell Dow Inc. Aminoguanidine spray drying process
WO1998024410A2 (en) * 1996-12-03 1998-06-11 Schering-Plough Kabushiki Kaisha Controlled release matrix tablet and method for its preparation
KR100611855B1 (ko) * 2001-07-30 2006-08-11 디에스엠 아이피 어셋츠 비.브이. 에피갈로카테킨 갈레이트용 조성물
PT1469833T (pt) 2002-02-01 2021-07-13 Bend Res Inc Método para produzir dispersões de fármaco amorfo sólido seco por pulverização homogéneas utilizando aparelho de secagem por pulverização modificado
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
UY28583A1 (es) * 2003-10-30 2005-05-31 Roche Consumer Health Ag Forma de presentación del naproxeno sodico
JP2008222567A (ja) * 2007-03-08 2008-09-25 Iwate Univ 微粒子の製造方法
TW201113266A (en) * 2009-09-02 2011-04-16 Ziopharm Oncology Inc Pharmaceutical formulations for indibulin
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers
US20190105274A1 (en) * 2015-07-13 2019-04-11 Kyowa Hakko Bio Co., Ltd. Tablets containing arginine at high concentration
JP6619644B2 (ja) * 2015-12-22 2019-12-11 アサヒグループ食品株式会社 錠剤の製造方法、及び錠剤原料用顆粒の製造方法
JP7163015B2 (ja) * 2016-10-31 2022-10-31 エスエス製薬株式会社 経口固形組成物
US20220280461A1 (en) * 2019-08-26 2022-09-08 Dsm Ip Assets B.V. Solid oral dosage form comprising naproxen and vitamin b12

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
ES2058288T3 (es) * 1987-07-08 1994-11-01 American Home Prod Composiciones de ibuprofen secadas por atomizacion.
IT1226549B (it) * 1988-07-12 1991-01-24 Resa Farma Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.

Also Published As

Publication number Publication date
AU6837590A (en) 1991-06-27
ZA9010353B (en) 1992-08-26
ES2063296T3 (es) 1995-01-01
JPH05320045A (ja) 1993-12-03
NZ236631A (en) 1993-03-26
HUT59594A (en) 1992-06-29
FI906372A0 (fi) 1990-12-21
CA2032956A1 (en) 1991-06-23
DE69011836T2 (de) 1995-03-09
FI906372A (fi) 1991-06-23
ATE110267T1 (de) 1994-09-15
DE69011836D1 (de) 1994-09-29
EP0436373B1 (en) 1994-08-24
KR910011241A (ko) 1991-08-07
EP0436373A1 (en) 1991-07-10
NO905557L (no) 1991-06-24
PT96229B (pt) 1998-06-30
AU640725B2 (en) 1993-09-02
IE904666A1 (en) 1991-07-17
IL96749A0 (en) 1991-09-16
NO905557D0 (no) 1990-12-21
HU908395D0 (en) 1991-07-29

Similar Documents

Publication Publication Date Title
PT96229A (pt) Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico
ATE66141T1 (de) Pharmazeutische zusammensetzung.
BR9206996A (pt) Composição adequada para preparar esferóides por esferoidização processo para produzir um material em partículas processo para produzir uma forma de dosagem de sólido esferoidizado em partículas e forma de dosagem sólida
KR880004805A (ko) 분무건조된 아세트아미노펜
AR011080A1 (es) Composicion en polvo seco, proceso para su preparacion y uso de dicha composicion para la fabricacion del medicamento
HUP9802516A2 (hu) Eljárás amorf termékek gyártására konvekciós szárítás útján
NO20001670L (no) Fremgangsmate for fremstilling av en smaksmaskert farmasoytisk blanding og smaksmaskert farmasoytisk blanding fremstilt ifolge denne fremgangsmaten, samt smaksmaskerte tyggbare tabletter
FI893504A (fi) Menetelmä terapeuttisesti käyttökelpoisen, mikro- ja/tai nanopartikkeleita sisältävän yhtenäisen, kiinteän ja huokoisen muodon valmistamiseksi
DK0575930T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske retardformer
KR910014120A (ko) 피모벤단의 경구용 약제학적 제제
ES2040733T3 (es) Medicamentos que contienen clodronato y procedimiento para su preparacion.
BR9913782A (pt) Processo de preparação de uma formualação galênica que compreende fenofibrato como princìpio ativo, formulação galênica, medicamento e utilizações de um meio lìquido e de partìculas de fenofibrato
JPS5474855A (en) Preparation of finely divided soluble cellulose derivative
CA1268706A (en) Method for simultaneously drying and granulating extract substances from deproteinized calves blood
PT1100540E (pt) Processo para a preparacao de gel de sucralfato seco granular e poroso
BR1100487A (pt) Processo para a preparação de pelotas e medicamentos para a administração oral
NO874311D0 (no) Fremgangsmaate for fremstilling av et bindemiddelfritt celiprololhydroklorid-granulat som kan tabletteres.
RU2183119C1 (ru) Фармацевтическая композиция, обладающая спазмолитической активностью, способ ее получения
CS199882B1 (cs) Spfieob výroby stabilizovaného vysokonapučiavého natrifikovaného bentonitu
JPS6026093B2 (ja) ゲフアルナート含有固型製剤の製造方法
JPS60243080A (ja) 塩酸カルボクロメン含水結晶
JPS56156214A (en) Preparation of tableting enteric microcapsule
KR900000075A (ko) 장용성 과립제의 제조방법
RU98115790A (ru) Способ получения таблеток ранитидина
TH34788A (th) การปรับปรุงกลิ่นรสของสารทางเภสัชกรรม

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910506

FG3A Patent granted, date of granting

Effective date: 19980313

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990930